BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23021051)

  • 1. Fibrous and fibrohistiocytic neoplasms: an update.
    Clarke LE
    Dermatol Clin; 2012 Oct; 30(4):643-56, vi. PubMed ID: 23021051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Podoplanin expression in fibrous histiocytomas and cellular neurothekeomas.
    Kaddu S; Leinweber B
    Am J Dermatopathol; 2009 Apr; 31(2):137-9. PubMed ID: 19318798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High proliferative activity excludes dermatofibroma: report of the utility of MIB-1 in the differential diagnosis of selected fibrohistiocytic tumors.
    Hanly AJ; Jordà M; Elgart GW; Badiavas E; Nassiri M; Nadji M
    Arch Pathol Lab Med; 2006 Jun; 130(6):831-4. PubMed ID: 16740036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential gene expression profiles of neurothekeomas and nerve sheath myxomas by microarray analysis.
    Sheth S; Li X; Binder S; Dry SM
    Mod Pathol; 2011 Mar; 24(3):343-54. PubMed ID: 21297585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyalinized collagen in a dermatofibrosarcoma protuberans after treatment with imatinib mesylate.
    Thomison J; McCarter M; McClain D; Golitz LE; Goldenberg G
    J Cutan Pathol; 2008 Nov; 35(11):1003-6. PubMed ID: 18544062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of advanced dermatofibrosarcoma protuberans with imatinib mesylate with or without surgical resection.
    Rutkowski P; Dębiec-Rychter M; Nowecki Z; Michej W; Symonides M; Ptaszynski K; Ruka W
    J Eur Acad Dermatol Venereol; 2011 Mar; 25(3):264-70. PubMed ID: 20569296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fibrohistiocytic tumors of the skin: a heterogeneous group of superficially located mesenchymal neoplasms].
    Mentzel T
    Pathologe; 2015 Feb; 36(1):79-88. PubMed ID: 25589356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myxoid dermatofibrosarcoma protuberans: clinicopathologic, immunohistochemical, and molecular analysis of eight cases.
    Mentzel T; Schärer L; Kazakov DV; Michal M
    Am J Dermatopathol; 2007 Oct; 29(5):443-8. PubMed ID: 17890911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fibrohistiocytic skin tumors].
    Hügel H
    J Dtsch Dermatol Ges; 2006 Jul; 4(7):544-55. PubMed ID: 16827912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fibrohistiocytic tumor of skin].
    Wang J
    Zhonghua Bing Li Xue Za Zhi; 2013 Feb; 42(2):134-7. PubMed ID: 23710926
    [No Abstract]   [Full Text] [Related]  

  • 11. Imatinib mesylate in a patient with metastatic disease originating from a dermatofibrosarcoma protuberans of the scalp.
    Kasper B; Lossignol D; Gil T; Flamen P; De Saint Aubain N; Awada A
    Anticancer Drugs; 2006 Nov; 17(10):1223-5. PubMed ID: 17075323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein D in CD34-positive and CD34-negative cutaneous neoplasms: a useful marker in differentiating superficial acral fibromyxoma from dermatofibrosarcoma protuberans.
    Lisovsky M; Hoang MP; Dresser KA; Kapur P; Bhawan J; Mahalingam M
    Mod Pathol; 2008 Jan; 21(1):31-8. PubMed ID: 17885669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advanced dermatofibrosarcoma protuberans treated with imatinib mesylate].
    Zhu JH; Li QW; Xiao WH; Sun JZ; Wang RL; Lu JY
    Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):470-2. PubMed ID: 21875491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update on plexiform fibrohistiocytic tumor and addition of 66 new cases from the Armed Forces Institute of Pathology, in honor of Franz M. Enzinger, MD.
    Moosavi C; Jha P; Fanburg-Smith JC
    Ann Diagn Pathol; 2007 Oct; 11(5):313-9. PubMed ID: 17870015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular neurothekeoma: detailed characterization in a series of 133 cases.
    Hornick JL; Fletcher CD
    Am J Surg Pathol; 2007 Mar; 31(3):329-40. PubMed ID: 17325474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous CD34+ spindle cell neoplasms: Histopathologic features distinguish spindle cell lipoma, solitary fibrous tumor, and dermatofibrosarcoma protuberans.
    Wood L; Fountaine TJ; Rosamilia L; Helm KF; Clarke LE
    Am J Dermatopathol; 2010 Dec; 32(8):764-8. PubMed ID: 20559119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermatofibrosarcoma protuberans: a partial response to imatinib therapy.
    Mehrany K; Swanson NA; Heinrich MC; Weenig RH; Lee KK; White CR; Devere TS
    Dermatol Surg; 2006 Mar; 32(3):456-9. PubMed ID: 16640697
    [No Abstract]   [Full Text] [Related]  

  • 18. Fibrohistiocytic lipoma: twelve cases of a previously undescribed benign fatty tumor.
    Marshall-Taylor C; Fanburg-Smith JC
    Ann Diagn Pathol; 2000 Dec; 4(6):354-60. PubMed ID: 11149965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imatinib mesylate in the treatment of a large unresectable dermatofibrosarcoma protuberans: a case study.
    Savoia P; Ortoncelli M; Quaglino P; Bernengo MG
    Dermatol Surg; 2006 Aug; 32(8):1097-102. PubMed ID: 16918576
    [No Abstract]   [Full Text] [Related]  

  • 20. Imatinib mesylate for children with dermatofibrosarcoma protuberans (DFSP).
    Gooskens SL; Oranje AP; van Adrichem LN; de Waard-van der Spek FB; den Hollander JC; van de Ven CP; van den Heuvel-Eibrink MM
    Pediatr Blood Cancer; 2010 Aug; 55(2):369-73. PubMed ID: 20582941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.